Shares of Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.56 and traded as low as $0.51. Elite Pharmaceuticals shares last traded at $0.56, with a volume of 1,988,049 shares trading hands.
Elite Pharmaceuticals Stock Down 0.3 %
The company has a quick ratio of 2.42, a current ratio of 3.52 and a debt-to-equity ratio of 0.10. The firm’s 50-day moving average price is $0.56 and its 200 day moving average price is $0.37. The firm has a market cap of $596.42 million, a P/E ratio of -55.83 and a beta of 0.25.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Read More
- Five stocks we like better than Elite Pharmaceuticals
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- What Are the U.K. Market Holidays? How to Invest and Trade
- These 3 Quirky ETFs May Be Strong Plays in 2025
- About the Markup Calculator
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
